þ
|
QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
¨
|
TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF
1934
|
Illinois
|
36-1924025
|
(State
of Incorporation)
|
(I.R.S.
Employer Identification No.)
|
200
Wilmot Road, Deerfield, Illinois
|
60015
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Yes
þ No
¨
|
Large
accelerated filer þ Accelerated
Filer ¨ Non-accelerated
filer¨
|
Yes¨ No
þ
|
Item
1.
|
Consolidated
Condensed Financial Statements (Unaudited)
|
|||
a)
|
4
|
|||
b)
|
5
|
|||
c)
|
6
|
|||
d)
|
7
|
|||
Item
2.
|
9
|
|||
Item
3.
|
15
|
|||
Item
4.
|
15
|
Item
2.
|
16
|
|
Item
4.
|
16
|
|
Item
6.
|
18
|
CONSOLIDATED
CONDENSED BALANCE SHEETS
|
|||||||
(UNAUDITED)
|
|||||||
(Dollars
in Millions)
|
|||||||
February
28,
|
August
31,
|
||||||
2006
|
2005
|
||||||
Assets
|
|||||||
Current
Assets:
|
|||||||
Cash
and cash equivalents
|
$
|
578.8
|
$
|
576.8
|
|||
Short
term investments - available for sale
|
646.0
|
494.8
|
|||||
Accounts
receivable, net
|
1,848.2
|
1,396.3
|
|||||
Inventories
|
5,616.0
|
5,592.7
|
|||||
Other
current assets
|
220.7
|
255.9
|
|||||
Total
Current Assets
|
8,909.7
|
8,316.5
|
|||||
Property
and Equipment, at cost, less accumulated depreciation and
amortization
of $2,147.6 at February 28 and $1,985.2 at August 31
|
6,501.4
|
6,165.0
|
|||||
Other
Non-Current Assets
|
228.0
|
127.3
|
|||||
Total
Assets
|
$
|
15,639.1
|
$
|
14,608.8
|
|||
Liabilities
& Shareholders' Equity
|
|||||||
Current
Liabilities:
|
|||||||
Trade
accounts payable
|
$
|
3,270.2
|
$
|
2,918.2
|
|||
Accrued
expenses and other liabilities
|
1,506.2
|
1,491.9
|
|||||
Income
taxes
|
193.2
|
70.9
|
|||||
Total
Current Liabilities
|
4,969.6
|
4,481.0
|
|||||
Non-Current
Liabilities:
|
|||||||
Deferred
income taxes
|
171.2
|
240.4
|
|||||
Other
non-current liabilities
|
1,045.2
|
997.7
|
|||||
Total
Non-Current Liabilities
|
1,216.4
|
1,238.1
|
|||||
Shareholders'
Equity:
|
|||||||
Preferred
stock $.0625 par value; authorized 32 million shares, none
issued
|
-
|
-
|
|||||
Common
stock $.078125 par value; authorized 3.2 billion shares;
issued
1,025,400,000 at February 28 and August 31
|
80.1
|
80.1
|
|||||
Paid-in
capital
|
597.4
|
565.0
|
|||||
Employee
stock loan receivable
|
(81.7
|
)
|
(76.8
|
)
|
|||
Retained
earnings
|
9,574.0
|
8,836.3
|
|||||
Treasury
stock, at cost; 16,497,187 shares at February 28
and
11,887,953 shares at August 31
|
(716.7
|
)
|
(514.9
|
)
|
|||
Total
Shareholders' Equity
|
9,453.1
|
8,889.7
|
|||||
Total
Liabilities & Shareholders' Equity
|
$
|
15,639.1
|
$
|
14,608.8
|
CONSOLIDATED
CONDENSED STATEMENTS OF EARNINGS
|
|||||||||||||
(UNAUDITED)
|
|||||||||||||
(In
Millions Except Per Share Data)
|
|||||||||||||
Three
Months Ended
|
Six
Months Ended
|
||||||||||||
February
28,
|
|
|
February
28,
|
|
|
February
28,
|
|
|
February
28,
|
|
|||
|
|
|
2006
|
|
|
2005
|
|
|
2006
|
|
|
2005
|
|
Net
sales
|
$
|
12,163.1
|
$
|
10,987.0
|
$
|
23,063.5
|
$
|
20,876.1
|
|||||
Costs
and Deductions:
|
|||||||||||||
Cost
of sales
|
8,703.8
|
7,856.4
|
16,601.7
|
15,037.6
|
|||||||||
Selling,
occupancy and administration
|
2,638.4
|
2,355.0
|
5,099.1
|
4,556.8
|
|||||||||
11,342.2
|
10,211.4
|
21,700.8
|
19,594.4
|
||||||||||
Other
Income:
|
|||||||||||||
Interest
income
|
10.0
|
6.7
|
16.8
|
11.8
|
|||||||||
Earnings
before income tax provision
|
830.9
|
782.3
|
1,379.5
|
1,293.5
|
|||||||||
Income
tax provision
|
307.4
|
291.4
|
510.4
|
474.0
|
|||||||||
Net
earnings
|
$
|
523.5
|
$
|
490.9
|
$
|
869.1
|
$
|
819.5
|
|||||
Per
share-
|
|||||||||||||
Basic
|
$
|
.52
|
$
|
.48
|
$
|
.86
|
$
|
.80
|
|||||
Diluted
|
$
|
.51
|
$
|
.48
|
$
|
.85
|
$
|
.80
|
|||||
Dividends
declared
|
$
|
.065
|
$
|
.0525
|
$
|
.13
|
$
|
.105
|
|||||
Average
shares outstanding
|
1,010.7
|
1,021.6
|
1,011.7
|
1,022.3
|
|||||||||
Dilutive
effect of stock options
|
9.3
|
8.0
|
9.4
|
7.4
|
|||||||||
Average
shares outstanding assuming dilution
|
1,020.0
|
1,029.6
|
1,021.1
|
1,029.7
|
|||||||||
|
|||||||
CONSOLIDATED
CONDENSED STATEMENTS OF CASH FLOWS
|
|||||||
(UNAUDITED)
|
|||||||
(Dollars
in Millions)
|
|||||||
Six
Months Ended
|
|||||||
February
28,
|
February
28,
|
||||||
2006
|
2005
|
||||||
Net
cash provided by operating activities
|
$
|
1,266.3
|
$
|
586.9
|
|||
Cash
flows from investing activities:
|
|||||||
Purchases
of short term investments available for sale
|
(4,018.0
|
)
|
(5,080.2
|
)
|
|||
Proceeds
from sale of short term investments available for sale
|
3,874.2
|
5,346.0
|
|||||
Additions
to property and equipment
|
(601.2
|
)
|
(568.4
|
)
|
|||
Disposition
of property and equipment
|
2.4
|
1.8
|
|||||
Business
acquisitions, net of cash received
|
(131.3
|
)
|
-
|
||||
Net
cash used for investing activities
|
(873.9
|
)
|
(300.8
|
)
|
|||
Cash
flows from financing activities:
|
|||||||
Stock
purchases
|
(344.7
|
)
|
(284.5
|
)
|
|||
Proceeds
related to employee stock plans
|
98.4
|
91.8
|
|||||
Cash
dividends paid
|
(131.7
|
)
|
(107.5
|
)
|
|||
Other
|
(12.4
|
)
|
23.2
|
||||
Net
cash used for financing activities
|
(390.4
|
)
|
(277.0
|
)
|
|||
Changes
in cash and cash equivalents:
|
|||||||
Net
increase in cash and cash equivalents
|
2.0
|
9.1
|
|||||
Cash
and cash equivalents at beginning of year
|
576.8
|
444.0
|
|||||
Cash
and cash equivalents at end of period
|
$
|
578.8
|
$
|
453.1
|
|||
(1) |
Inventories
are valued on a lower of last-in, first-out (LIFO) cost or market
basis.
At February 28, 2006 and August 31, 2005, inventories would have
been
greater by $849.2 million and $804.2 million respectively, if they
had
been valued on a lower of first-in, first-out (FIFO) cost or market
basis.
LIFO inventory costs can only be determined annually when inflation
rates
and inventory levels are finalized; therefore, LIFO inventory costs
for
interim financial statements are estimated. Included in inventory
are
product cost and inbound freight. Cost of sales is primarily based
upon
point-of-sale scanning information with an estimate for shrinkage
and
adjusted based on periodic
inventories.
|
(2) |
The
principal retirement plan for employees is the Walgreen Profit-Sharing
Retirement Trust to which both the company and the employees contribute.
The company's contribution, which is determined annually at the discretion
of the Board of Directors, has historically related to pre-tax income.
The
profit-sharing provision was $73.9 million for the second quarter
and
$122.7 million for the six-month period of this fiscal year. This
compares
to $69.6 million and $115.1 million for the same periods last year.
The
company's contributions were $216.1 million during the second quarter
and
the six month period ended February 28, 2006. This compares to $73.3
million for the quarter and $262.3 million for the six-month period
ended
February 28, 2005.
|
(3) |
Prior
to fiscal 2006, as permitted under Statement of Financial Accounting
Standards (SFAS) No. 123, "Accounting for Stock-Based Compensation,"
the
company applied Accounting Principles Board (APB) Opinion No. 25
and
related interpretations in accounting for its stock-based compensation
plans. Under APB Opinion No. 25, compensation expense was recognized
for
stock option grants if the exercise price was below the fair value
of the
underlying stock at the measurement date.
|
As
of September 1, 2005, the company adopted SFAS No. 123(R), "Share-Based
Payment," using the modified prospective transition method. Under
this
method, compensation expense is recognized for new grants beginning
this
fiscal year and any unvested grants prior to the adoption of SFAS
No.
123(R). The company recognizes compensation expense on a straight-line
basis over the employee's vesting period or to the employee's retirement
eligible date, if earlier. In accordance with the modified prospective
transition method, the financial statements for prior periods have
not
been restated. Total stock-based compensation expense for the three
months
and six months ended February 28, 2006, was $27.4 million and $63.6
million, respectively. The recognized tax benefit was $10.1 million
and
$23.5 million, respectively. For the quarter ended February 28, 2006,
the
company did not issue any significant grants.
|
In
November 2005, the FASB issued FSP No. 123(R)-3, "Transition Election
Related to Accounting for the Tax Effects of Share-Based Payment
Awards."
This pronouncement provides an alternative method of calculating
the
excess tax benefits available to absorb any tax deficiencies recognized
subsequent to the adoption of SFAS No. 123(R). The company has until
November 2006 to make a one-time election to adopt the transition
method.
The company is currently evaluating FSP 123(R)-3; this one-time election
will not affect operating income or net earnings.
|
Had
compensation costs been determined consistent with the method of
SFAS No.
123 for options granted during the three and six months ended February
28,
2005, pro forma net earnings and net earnings per common share would
have
been as follows:
|
(In
Millions Except Per Share Data)
|
Three
Months Ended
February
28, 2005
|
Six
Months Ended February
28, 2005
|
|||||
Net
Earnings, as reported
|
$
|
490.9
|
$
|
819.5
|
|||
Add: Stock-based
employee compensation expense included in reported net income,
net of
related tax effects
|
.1
|
.1
|
|||||
Deduct: Total
stock-based employee compensation expense determined under fair
value
based method for all awards, net of related tax effects
|
(16.7
|
)
|
(29.8
|
)
|
|||
Pro
forma net earnings
|
$
|
474.3
|
$
|
789.8
|
|||
Earnings
per share-
|
|||||||
Basic
- as reported
|
$
|
.48
|
$
|
.80
|
|||
Basic
- pro forma
|
$
|
.46
|
$
|
.77
|
|||
Diluted
- as reported
|
$
|
.48
|
$
|
.80
|
|||
Diluted
- pro forma
|
$
|
.46
|
$
|
.77
|
(4) |
The
company provides certain health insurance benefits for retired employees
who meet eligibility requirements, including age, years of service
and
date of hire. The costs of these benefits are accrued over the period
earned. The company's postretirement health benefit plans currently
are
not funded.
|
Three
Months Ended
|
Six
Months Ended
|
||||||||||||
|
February
28,
|
February
28,
|
February
28,
|
February
28,
|
|||||||||
Components
of Net Periodic Benefit Costs (In Millions)
|
2006
|
2005
|
2006
|
2005
|
|||||||||
Service
cost
|
$
|
4.6
|
$
|
5.6
|
$
|
9.1
|
$
|
11.2
|
|||||
Interest
cost
|
5.3
|
6.3
|
10.7
|
12.7
|
|||||||||
Amortization
of actuarial loss
|
2.2
|
2.5
|
4.4
|
5.0
|
|||||||||
Amortization
of prior service cost
|
(1.0
|
)
|
(0.5
|
)
|
(2.0
|
)
|
(1.0
|
)
|
|||||
Total
postretirement benefit cost
|
$
|
11.1
|
$
|
13.9
|
$
|
22.2
|
$
|
27.9
|
(5) |
Litigation
settlement gains, which were classified as Other Income in the second
quarter of fiscal 2005, have been reclassified as reductions to Selling,
Occupancy and Administrative
Expenses.
|
Percentage
Increases
|
||
Three
Months Ended
February
28, 2006
|
Six
Months Ended
February
28, 2006
|
|
Net
Sales
|
10.7
|
10.5
|
Net
Earnings
|
6.6
|
6.1
|
Comparable
Drugstore Sales
|
6.5
|
6.8
|
Prescription
Sales
|
11.1
|
10.7
|
Comparable
Prescription Sales
|
7.4
|
7.6
|
Front-End
Sales
|
10.7
|
10.7
|
Comparable
Front-End Sales
|
5.0
|
5.6
|
Percent
to Sales
|
||||
Three
Months Ended
|
Six
Months Ended
|
|||
February
28,
|
February
28,
|
February
28,
|
February
28,
|
|
2006
|
2005
|
2006
|
2005
|
|
Gross
Margin
|
28.4
|
28.5
|
28.0
|
28.0
|
Selling,
Occupancy and
|
||||
Administration
Expenses
|
21.7
|
21.4
|
22.1
|
21.8
|
Other
Statistics
|
||||
Three
Months Ended
|
Six
Months Ended
|
|||
February
28,
2006
|
February
28,
2005
|
February
28,
2006
|
February
28,
2005
|
|
Prescription
Sales as a % of Net
Sales
|
61.5
|
61.2
|
62.9
|
62.8
|
Third
Party Sales as a % of Prescription Sales
|
92.7
|
92.7
|
92.6
|
92.7
|
Total
Number of Stores*
|
5,156
|
4,769
|
||
*The
store total now includes 37 home care locations. Last year's numbers
have
been adjusted
to include home care locations for
consistency.
|
Liability
for closed locations -
|
|
The
liability is based on the present value of future rent obligations
and
other related costs (net of estimated sublease rent) to the first
lease
option date.
|
|
Liability
for insurance claims -
|
|
The
liability for insurance claims is recorded based on estimates for
claims
incurred. The provisions are estimated in part by considering historical
claims experience, demographic factors and other actuarial
assumptions.
|
|
Vendor
allowances -
|
|
Vendor
allowances are principally received as a result of purchase levels,
sales
or promotion of vendors' products. Allowances are generally recorded
as a
reduction of inventory and are recognized as a reduction of cost
of sales
when the related merchandise is sold. Those allowances received for
promoting vendors' products are offset against advertising expense
and
result in a reduction of selling, occupancy and administration expense
to
the extent of advertising incurred, with the excess treated as a
reduction
of inventory costs.
|
|
Allowance
for doubtful accounts -
|
|
The
provision for bad debt is based on both specific receivables and
historic
write-off percentages.
|
|
Cost
of sales -
|
|
Drugstore
cost of sales is primarily derived based on point-of-sale scanning
information with an estimate for shrinkage and adjusted based on
periodic
inventories.
|
Payments
Due by Period (In Millions)
|
||||||||||||||||
|
|
Total
|
|
|
Less
than 1 Year
|
|
|
1-3
Years
|
|
|
3-5
Years
|
|
|
Over
5 Years
|
|
|
Operating
leases* (1)
|
$
|
24,727.1
|
$
|
1,401.3
|
$
|
2,867.5
|
$
|
2,790.6
|
$
|
17,667.7
|
||||||
Purchase
obligations (2):
|
||||||||||||||||
Open
inventory purchase orders*
|
948.6
|
948.6
|
-
|
-
|
-
|
|||||||||||
Real
estate development*
|
708.5
|
708.5
|
-
|
-
|
-
|
|||||||||||
Other
corporate obligations*
|
544.1
|
193.2
|
251.9
|
87.6
|
11.4
|
|||||||||||
Insurance
|
442.9
|
154.4
|
114.6
|
61.3
|
112.6
|
|||||||||||
Retiree
health & life
|
275.0
|
6.7
|
14.1
|
18.7
|
235.5
|
|||||||||||
Closed
location obligations
|
78.7
|
19.0
|
28.6
|
16.8
|
14.3
|
|||||||||||
Capital
lease obligations(1)
|
38.2
|
.9
|
1.9
|
2.1
|
33.3
|
|||||||||||
Other
long-term liabilities reflected on the balance sheet
|
422.0
|
30.6
|
42.0
|
40.2
|
309.2
|
|||||||||||
Total
|
$
|
28,185.1
|
$
|
3,463.2
|
$
|
3,320.6
|
$
|
3,017.3
|
$
|
18.384.0
|
(1)
|
The
above amounts for capital leases and operating leases do not
include
certain operating expenses under these leases such as common
area
maintenance, insurance and real estate taxes. These expenses
for the
company's most recent fiscal year were $207.4
million.
|
(2)
|
The
purchase obligations include agreements to purchase goods or
services that
are enforceable and legally binding and that specify all significant
terms, including open purchase
orders.
|
Inventory
obligations
|
$
|
25.2
|
||
Real
estate development
|
1.7
|
|||
Insurance
|
292.2
|
|||
Total
|
$
|
319.1
|
PART
II. OTHER INFORMATION
|
(c)
|
The
following table provides information about purchases by the company
during
the quarter ended February 28, 2006 of equity securities that are
registered by the company pursuant to Section 12 of the Exchange
Act:
|
ISSUER
PURCHASES OF EQUITY SECURITIES
|
|||||||||||||
Period
|
Total
Number of Shares
Purchased (1)
|
Average
Price Paid
per Share
|
Total
Number of Shares Purchased as Part of Publicly Announced Plans
or
Programs
|
Approximate
Dollar Value of Shares that May Yet Be Purchased Under the Plans
or
Programs
(2)
|
|||||||||
12/01/2005
- 12/31/2005
|
-
|
$
|
-
|
-
|
$
|
573,752,400
|
|||||||
01/01/2006
- 01/31/2006
|
2,727,000
|
|
43.5708
|
1,202,000
|
521,373,613
|
||||||||
02/01/2006
- 02/28/2006
|
1,533,000
|
|
43.9344
|
690,000
|
491,138,168
|
||||||||
Total
|
4,260,000
|
$
|
43.7017
|
1,892,000
|
$
|
491,138,168 |
(1)
|
The
company repurchased an aggregate of 2,368,000 shares of its common
stock
in open-market transactions to satisfy the requirements of the
company's
employee stock purchase and option plans, as well as the company's
Nonemployee Director Stock Plan.
|
(2)
|
On
July 14, 2004, the Board of Directors approved a stock repurchase
program,
pursuant to which up to $1 billion of the company's common stock
may be
repurchased. This program was announced in the company's report
on Form
8-K, which was filed on July 15, 2004. The total remaining authorization
under the repurchase programs was $491,138,168 as of February 28,
2006.
The expiration date of the repurchase program is July 13,
2008.
|
(a)
|
The
company held its Annual Meeting of Shareholders on January 11,
2006.
|
(c)
|
(1)
The shareholders voted for election of the following directors to
serve
until the next annual meeting or until their successors are elected
and
qualified:
|
Votes
For
|
Votes
Withheld
|
|
David
W. Bernauer
|
848,556,348
|
20,661,935
|
William
C. Foote
|
851,582,608
|
17,635,674
|
James
J. Howard
|
855,475,464
|
13,742,818
|
Alan
G. McNally
|
859,577,102
|
9,641,180
|
Cordell
Reed
|
855,900,032
|
13,318,250
|
Jeffrey
A. Rein
|
853,886,212
|
15,332,070
|
David
Y. Schwartz
|
858,935,119
|
10,283,163
|
John
B. Schwemm
|
849,522,459
|
19,695,824
|
James
A. Skinner
|
859,739,301
|
9,478,981
|
Marilou
M. von Ferstel
|
858,877,220
|
10,341,062
|
Charles
R. Walgreen III
|
858,973,387
|
10,244,895
|
3.
|
(a)
|
Articles
of Incorporation of the company, as amended, filed with the Securities
and
Exchange Commission as Exhibit 3(a) to the company's Quarterly
Report on
Form 10-Q for the quarter ended February 28, 1999, and incorporated
by
reference herein.
|
|
(b)
|
By-Laws
of the company, as amended and restated effective as of July 9,
2003,
filed with the Securities and Exchange Commission as Exhibit 3(b)
to the
company's quarterly report on Form 10-Q for the quarter ended November
30,
2003, and incorporated by reference herein.
|
||
4.
|
(a)
|
Rights
Agreement dated as of July 10, 1996, between the company and Harris
Trust
and Savings Bank, filed with the Securities and Exchange Commission
as
Exhibit 1 to Registration Statement on Form 8-A on July 11, 1996
(File No.
1-604), and incorporated by reference herein.
|
|
10.
|
(a)
|
Walgreen
Co. Executive Stock Option Plan (effective January 11, 2006), as
amended
and restated, filed with the Securities and Exchange Commission
as Exhibit
10.1 to the company's Current Report on Form 8-K dated January
17, 2006,
and incorporated by reference herein.
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
||
31.2
|
Certification
of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
||
32.1
|
Certification
of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, 18
U.S.C. Section 1350.
|
||
32.1
|
Certification
of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, 18
U.S.C. Section 1350.
|
WALGREEN
CO.
|
|
(Registrant)
|
|
Dated:
April 5, 2006
|
/s/
W.M. Rudolphsen
|
W.M.
Rudolphsen
|
|
Senior
Vice President
|
|
(Chief
Financial Officer)
|
|
Dated:
April 4, 2006
|
/s/
M.M. Scholz
|
M.M.
Scholz
|
|
Controller
|
|
(Chief
Accounting Officer)
|
|